CAS 219716-33-3
:Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produtos.
Visilizumab
CAS:Humanized monoclonal antibody targeting the CD3 receptor; possible ulcerative colitis and Chrohn's disease treatmentVisilizumab
CAS:Visilizumab is a humanized anti-CD3 IgG2 mAb with low Fc binding, modulating T-cell function for ulcerative colitis and Crohn's.Pureza:95%Cor e Forma:LiquidPeso molecular:144.64 kDa
